Underground decline now runs in parallel with Grants, and the Darwin logistics chain just proved itself live.
Core Lithium (ASX:CXO) has done two things in one announcement that, taken together, change the texture of the Finniss restart story. The portal cut at the BP33 underground decline is now done and Develop Global has mobilised to start the decline development. At the same time, the first shipment of 20kt of lithium fines and 5kt of stockpiled spodumene concentrate has left Darwin Port.
Until today, the Finniss restart was a funding package, a contract award and a lot of earthmoving. It was credible, but it was still mostly forward-looking. The shipment turns that into actual revenue heading to a buyer, with payment expected before the end of the June quarter.
The portal cut matters for a different reason. It marks the moment Finniss stops being a single-pit open cut story and starts becoming the longer-life underground operation that the bull case has always rested on. First development ore from BP33 is targeted for mid-2027, with nameplate production by mid-2028.
In three months since the March Final Investment Decision, management has awarded every major mining contracts, started the Grants open pit, sold two DSO fines parcels plus the spodumene stockpile, and now opened the underground face. The execution pace is the story investors should be focused on.
Why BP33 is the part of Finniss that actually matters long term
Grants is the open pit that pays the early bills. It is expected to deliver roughly 780 to 790kt of ore and 130 to 140kt of SC5 spodumene, with processing starting in the September quarter and shipments running through calendar 2027.
But Grants is the appetiser. BP33 is the main course. It is one large sub-vertical pegmatite with a mine life of more than 10 years and remains open at depth, which is mining shorthand for there is likely more down there.
Running the decline in parallel with open pit mining is the right call commercially. It means Core can fund underground development out of Grants cash flow rather than going back to the market, and that is the structural difference between this restart and the 2022 cycle that ended in tears.
The first shipment is small, but the logistics proof point is not
The 25kt combined shipment will not move the dial on revenue in isolation. What it does prove is that the mine-to-port chain that collapsed when Finniss went on care and maintenance in early 2024 has been successfully reactivated, end to end.
Darwin sits 88 kilometres from site by sealed road, which is a logistical advantage most Australian lithium projects can only dream about. The risk has never been whether the route works in theory. It was whether the trucking, port handling and offtake mechanics could be turned back on cleanly. This shipment says yes.
Worth noting, the spodumene concentrate moving today is stockpile material, not new production. The real test comes in the September quarter when Grants concentrate begins flowing through the DMS plant brownfields works that are still being completed.
What we are still watching from here
Our concern is the same one we flagged when the restart was funded. None of the future Finniss output is contracted, so the project remains fully exposed to wherever spodumene prices sit when serious tonnage starts flowing. Lithium has firmed through 2026, but the curve is not what anyone would call stable.
The second watch item is cost discipline through the underground build. Develop is a credible contractor and the staged ramp is sensible, but underground projects are where Australian lithium budgets historically slip. Investors should treat the mid-2027 first ore target as the next real test of management credibility.
The Investors Takeaway for Core Lithium
Three months of clean execution does not eliminate the lithium price risk, but it does change the conversation. Finniss is no longer a plan with a funding package attached. It is a producing operation with stockpile sales hitting the bank and an underground decline being cut.
We think the next genuine re-rating moment is not this shipment. It is the September quarter, when Grants concentrate starts flowing and the market gets its first look at real production economics under the restructured cost base. Until then, the price will mostly track the spodumene curve.
For readers who want the broader picture on how we have been tracking this turnaround, our prior coverage at stocksdownunder walks through the funding, the Glencore offtake and the stockpile sales that bridged the company to this point.
